Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma
- PMID: 15672431
- DOI: 10.1002/bjs.4887
Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma
Abstract
Background: Quality of life (QOL) is an important outcome measure after treatment of pancreatic and periampullary carcinoma. The aim of this prospective longitudinal study was to analyse QOL after surgery for resectable pancreatic or periampullary carcinoma.
Methods: Patients with potentially resectable tumours underwent pancreaticoduodenectomy (n = 72) or a double-bypass procedure (n = 42). They were asked to complete a questionnaire before laparotomy and at 2 weeks, 6 weeks, and 3, 6, 9 and 12 months after surgery. Fifty-nine patients completed a shortened questionnaire on a weekly basis.
Results: There was a temporary decrease in physical and gastrointestinal functioning after pancreaticoduodenectomy. A similar decrease in QOL was observed after double bypass, as well as decreases in mental functioning and overall QOL. Almost all QOL scores returned to preoperative values by about 3 months after surgery, although only briefly so in patients who had a double-bypass procedure. There were no differences between groups in the terminal stages of disease. A rapid decrease on all QOL scales was observed in the last 8 weeks before death.
Conclusion: Surgery for pancreatic and periampullary carcinoma was not associated with irreversible impairment or protracted recovery of QOL. The relatively long plateau phase after recovery supports the argument for surgical treatment, including surgical palliation in selected patients.
Similar articles
-
Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses.Ann Surg Oncol. 2006 Nov;13(11):1403-11. doi: 10.1245/s10434-006-9172-z. Epub 2006 Sep 29. Ann Surg Oncol. 2006. PMID: 17009141
-
Palliation of unresectable periampullary neoplasms. "surgical" versus "non-surgical" approach.Hepatogastroenterology. 2004 Sep-Oct;51(59):1282-5. Hepatogastroenterology. 2004. PMID: 15362733
-
Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1060-6. doi: 10.1016/j.ijrobp.2005.03.036. Epub 2005 Jun 22. Int J Radiat Oncol Biol Phys. 2005. PMID: 15978737
-
Surgical management of pancreatic carcinoma.Semin Oncol. 1996 Apr;23(2):200-12. Semin Oncol. 1996. PMID: 8623056 Review.
-
[Therapeutic strategy in neoplasia of the pancreas and ampulla].Ann Ital Chir. 2003 May-Jun;74(3):269-74. Ann Ital Chir. 2003. PMID: 14677281 Review. Italian.
Cited by
-
Cost-utility estimations of palliative care in patients with pancreatic adenocarcinoma: a retrospective analysis.World J Surg. 2013 Aug;37(8):1883-91. doi: 10.1007/s00268-013-2003-z. World J Surg. 2013. PMID: 23519293
-
Pancreatic cancer survivors' preferences, barriers, and facilitators related to physical activity and diet interventions.J Cancer Surviv. 2016 Dec;10(6):981-989. doi: 10.1007/s11764-016-0544-5. Epub 2016 Apr 30. J Cancer Surviv. 2016. PMID: 27138993 Free PMC article.
-
Symptom profiles and palliative care in advanced pancreatic cancer: a prospective study.Support Care Cancer. 2006 Nov;14(11):1126-33. doi: 10.1007/s00520-006-0067-0. Epub 2006 Apr 7. Support Care Cancer. 2006. PMID: 16601947
-
Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer.BMC Gastroenterol. 2015 Apr 2;15:44. doi: 10.1186/s12876-015-0270-x. BMC Gastroenterol. 2015. PMID: 25888495 Free PMC article.
-
Opportunities of improvement in the management of pancreatic and periampullary tumors.Scand J Gastroenterol. 2013 May;48(5):617-25. doi: 10.3109/00365521.2013.781218. Scand J Gastroenterol. 2013. PMID: 23597153 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical